← Back
A

$ Value

$0

Shares

7,888

Price

$0

Filed

Jan 2

Insider

Name

KEATING LAURIE

Title

CIK

0001620743

Roles

Director

Transaction Details

Transaction Date

2026-01-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,888

Footnotes

Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the "Compensation Program"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program). | The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service.

Filing Info

Accession No.

0001790340-26-000004

Form Type

4

Issuer CIK

0001790340

KEATING LAURIE's History

Date Ticker Type Value
2026-01-01 IMRX A $0
2025-06-13 IMRX A $0
2025-06-04 PEPG A $0

Other Insiders at IMRX (90d)

Insider Bought Sold Last
Matushansky Igor
Chief Medical Officer
2026-02-03
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
2026-02-03
Zeskind Benjamin J.
PRESIDENT AND CEO
2026-02-03
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
2026-02-03
Morales Mallory
SVP Finance, CAO
2026-02-03
Neufeld Leah R
CHIEF PEOPLE OFFICER
2026-03-13
Brakewood Harold Eugene
Chief Business Officer
2026-02-03